WHO Drug Information - Volume 34, No. 4

Overview

- The fourth issue of Volume 34, includes

Quality Assurance News:

• White Paper for the WHO International Meeting of World Pharmacopoeias – Value of Pharmacopoeial Standards for Access to Quality Medicines
• Study Report: Proficiency testing study on a WHO/TAL-trained methodology

Consultation Documents:

• Rifampicin (rifampicinum) – Draft proposal for inclusion in The International Pharmacopoeia
• Dolutegravir sodium (dolutegravirum natricum) – Draft proposal for inclusion in The International Pharmacopoeia
• Dolutegravir tablets (dolutegraviri compressi) – Draft proposal for inclusion in The International Pharmacopoeia
• Remdesivir (remdesivirum) – Draft proposal for inclusion in The International Pharmacopoeia
• Remdesivir intravenous infusion (remdesiviri infusio intraveno) - Draft proposal for inclusion in The International Pharmacopoeia
• WHO Guidelines on the Transfer of Technology in Pharmaceutical Manufacturing
• Oxygen (oxygenium) - Draft proposal for inclusion in The International Pharmacopoeia

ATC/DDD Classification

• ATC/DDD Classification (Temporary)
• ATC/DDD Classification (Final)

- Issue 4 concludes with List No. 124 of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances